PARVA Human

Parvin Alpha Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biological Functions

PARVA plays multifaceted roles in cellular processes:

  • Cell Adhesion and Motility: Integrates with integrin-linked kinase (ILK) and PINCH to form focal adhesion complexes, bridging extracellular matrix signals to actin cytoskeleton reorganization .

  • Cancer Progression:

    • Overexpression enhances lung cancer cell invasion, angiogenesis, and metastasis via ILK/Akt/GSK3β pathway activation .

    • Knockdown inhibits tumorigenicity and endothelial tube formation in vitro .

  • Cardiovascular Development: Essential for embryonic heart septation and vascular smooth muscle adhesion .

Research Findings in Oncology

Key studies highlight PARVA's oncogenic role:

Table 1: PARVA Modulation in Lung Cancer Models

ConditionEffectsMechanism
Overexpression↑ Invasion, colony formation, metastasis ILK phosphorylation → Akt/GSK3β activation
Knockdown↓ Tumorigenesis, tube formation ILK pathway suppression

Table 2: PARVA-Regulated Pathways

PathwayRole in CancerKey Molecules
ILK SignalingEnhances cell survival, invasion, and angiogenesis ILK, Akt, GSK3β
Cytoskeletal RemodelingFacilitates metastasis via actin dynamics Actin, Paxillin

Technical Applications of Recombinant PARVA

Recombinant PARVA is widely used in:

  • Mechanistic Studies: Investigating ILK-dependent signaling in cancer .

  • In Vitro Assays**: Migration, adhesion, and angiogenesis models .

Product ComparisonProspec Bio (PRO-1257) Boster Bio (PROTQ9NVD7)
HostE. coliHEK293T cells
TagHis-tagC-Myc/DDK
Concentration0.5 mg/mL>50 µg/mL

Clinical Implications

  • Biomarker Potential: Elevated PARVA correlates with poor prognosis in lung adenocarcinoma .

  • Therapeutic Target: ILK inhibitors (e.g., QLT0267) may counteract PARVA-driven metastasis .

Product Specs

Introduction
Alpha-parvin, also known as PARVA, is a protein belonging to the parvin family. This family is known for its actin-binding properties. PARVA plays a crucial role in several cellular processes, including cell adhesion, cytoskeleton organization, cell movement, and survival. Additionally, it is involved in the formation of cilia. Parvins are commonly found in focal contacts and possess calponin homology domains, which enable them to interact with actin filaments. PARVA is widely expressed throughout the body, with particularly high levels found in the heart, skeletal muscle, kidney, and liver.
Description
Recombinant PARVA Human, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 395 amino acids, with amino acids 1-372 representing the PARVA sequence, and has a molecular weight of 44.6 kDa. This protein is fused to a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The PARVA protein is supplied in a solution with a concentration of 0.5 mg/ml. The solution also contains 20 mM Tris-HCl buffer (pH 8.0), 0.15 M NaCl, 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure optimal long-term stability, adding a carrier protein like HSA or BSA (0.1%) is advisable. Repeated freezing and thawing of the product should be avoided.
Purity
The purity of this product is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
Alpha-parvin, Actopaxin, CH-ILKBP, Calponin-like integrin-linked kinase-binding protein, Matrix-remodeling-associated protein 2, PARVA, MXRA2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMATSPQK SPSVPKSPTP KSPPSRKKDD SFLGKLGGTL ARRKKAKEVS ELQEEGMNAI NLPLSPIPFE LDPEDTMLEE NEVRTMVDPN SRSDPKLQEL MKVLIDWIND VLVGERIIVK DLAEDLYDGQ VLQKLFEKLE SEKLNVAEVT QSEIAQKQKL QTVLEKINET LKLPPRSIKW NVDSVHAKSL VAILHLLVAL SQYFRAPIRL PDHVSIQVVV VQKREGILQS RQIQEEITGN TEALSGRHER DAFDTLFDHA PDKLNVVKKT LITFVNKHLN KLNLEVTELE TQFADGVYLV LLMGLLEGYF VPLHSFFLTP DSFEQKVLNV SFAFELMQDG GLEKPKPRPE DIVNCDLKST LRVLYNLFTK YRNVE.

Q&A

What is the PARVA gene and what protein does it encode?

The PARVA gene encodes the protein alpha-parvin in humans. Alpha-parvin is a critical component in multiple cellular processes, functioning primarily as a structural and signaling protein within the cell architecture. The protein participates in focal adhesion complexes and contributes to cytoskeletal organization that underpins cellular morphology and movement . Research approaches to understand PARVA gene expression typically include RT-PCR, Northern blotting, and RNA-seq methodologies that quantify transcription levels across different tissue types and experimental conditions.

What cellular functions does alpha-parvin govern in human tissues?

Alpha-parvin participates in numerous fundamental cellular processes that include:

  • Sarcomere organization in muscle cells

  • Smooth muscle cell contraction regulation

  • Reorganization of the actin cytoskeleton

  • Formation of lamellipodia during cell movement

  • Ciliogenesis in appropriate cell types

  • Establishment of cell polarity

  • Mediation of cell adhesion processes

  • Facilitation of cell spreading behaviors

  • Direction of cell migration pathways

Investigating these functions requires multiple experimental approaches including immunofluorescence microscopy, live cell imaging, and various biochemical assays that track protein-protein interactions and cytoskeletal dynamics.

How does PARVA contribute to cardiovascular development?

Alpha-parvin plays essential roles in cardiovascular development through several mechanisms. The protein is required for normal development of the embryonic cardiovascular system and correct septation of the heart outflow tract. Additionally, it facilitates sprouting angiogenesis and mediates the normal adhesion of vascular smooth muscle cells to endothelial cells during blood vessel formation and maturation .

Research methodologies to study these developmental roles typically involve:

  • Embryonic tissue sectioning and immunohistochemistry

  • Developmental timing analyses using controlled expression systems

  • Cardiovascular-specific knockout models

  • Ex vivo vessel formation assays

  • Endothelial-smooth muscle co-culture systems

What experimental systems are available for studying alpha-parvin across species?

Researchers can access various experimental tools for studying alpha-parvin across different mammalian species:

SpeciesAvailable Research ToolsApplications
Human (Homo sapiens)Multiple antibodies (HRP/FITC/Biotin conjugated), Recombinant proteins from various expression systemsELISA, Western Blot, Immunohistochemistry, Immunofluorescence
Mouse (Mus musculus)Antibodies with cross-reactivity, Recombinant proteinsELISA, Western Blot, Immunohistochemistry
Rat (Rattus norvegicus)Antibodies with cross-reactivity, Recombinant proteinsELISA, Western Blot, Immunohistochemistry

This cross-species availability facilitates comparative studies and translation between model organisms and human systems.

What methodological approaches best elucidate PARVA's interaction with the actin cytoskeleton?

Alpha-parvin's interaction with the actin cytoskeleton represents a critical aspect of its function in cell motility and morphology. To effectively investigate these interactions, researchers should implement:

  • Co-immunoprecipitation assays to identify direct binding partners

  • Proximity ligation assays to visualize protein-protein interactions in situ

  • FRET/FLIM microscopy to quantify dynamic interactions in living cells

  • Purified protein binding assays with actin filaments

  • Super-resolution microscopy (STORM, PALM) to visualize nanoscale organization

  • Actin treadmilling assays to assess effects on cytoskeletal dynamics

The combination of these approaches provides complementary data on both static and dynamic aspects of PARVA-actin interactions, offering insights into mechanical and signaling functions.

How can researchers effectively distinguish between direct and indirect effects of PARVA on cell polarity?

Establishing causality in PARVA's role in cell polarity requires sophisticated experimental designs:

  • Rescue experiments using structure-function mutants of PARVA

  • Acute protein inactivation using optogenetic or chemical genetic approaches

  • Domain-specific disruption of protein interactions

  • Temporal analysis using synchronized cell systems

  • Quantitative assessment of polarity markers with simultaneous PARVA visualization

  • Mathematical modeling of polarity formation with and without PARVA function

These approaches help delineate the direct mechanistic contributions of PARVA to polarity establishment versus secondary effects resulting from altered cytoskeletal organization or adhesion dynamics.

What are current technical challenges in studying PARVA's role in sprouting angiogenesis?

Investigating PARVA in angiogenesis presents specific methodological challenges:

  • Achieving endothelial-specific manipulation without affecting supporting cells

  • Distinguishing cell-autonomous effects from paracrine signaling

  • Visualizing real-time protein dynamics during sprouting events

  • Recapitulating the complex extracellular matrix environment in vitro

  • Quantifying subtle phenotypic changes in vessel morphology and function

  • Separating PARVA's roles in tip versus stalk cells during sprouting

Researchers can address these challenges through microfluidic angiogenesis models, endothelial-specific inducible genetic systems, advanced intravital imaging, and computational analysis of sprouting dynamics.

How should researchers approach investigating PARVA's temporal dynamics during cardiovascular development?

Studying the temporal aspects of PARVA function in cardiovascular development requires specialized techniques:

  • Time-controlled genetic deletion systems (inducible Cre-lox)

  • In utero manipulation of gene expression at specific developmental stages

  • Live imaging of embryonic cardiovascular structures

  • Stage-specific transcriptomic and proteomic profiling

  • 4D analysis of protein localization during heart development

  • Correlation of PARVA expression patterns with developmental milestones

These approaches help establish critical windows when PARVA function is essential and identify stage-specific interaction partners that may modulate its activity.

What contradictions exist in understanding PARVA's role in lamellipodia formation?

Current research shows both stimulatory and inhibitory roles for PARVA in lamellipodia formation, suggesting context-dependent functions. Methodological approaches to resolve these contradictions include:

  • Cell-type specific analysis of lamellipodia dynamics

  • Quantitative parameter measurement of lamellipodia properties (persistence, area, rate of formation)

  • Systematic testing across extracellular matrix composition conditions

  • Integration of mechanical stimulation with biochemical analysis

  • Single-cell analysis to account for heterogeneity within populations

  • Correlation with activity states of upstream regulators and downstream effectors

These systematic approaches can help identify specific conditions under which PARVA promotes versus inhibits lamellipodia formation.

What antibodies are most reliable for PARVA detection in human experimental systems?

Several validated antibodies are available for detecting human PARVA in research applications:

Antibody CodeSpecificityConjugationApplicationsSpecies Reactivity
CSB-PA017474GA01HUPARVAUnconjugatedELISA, WB, IHCHuman, Mouse, Rat
CSB-PA868328LA01HUPARVAUnconjugatedELISA, WB, IHC, IFHuman, Rat
CSB-PA868328LB01HUPARVAHRPELISAHuman
CSB-PA868328LC01HUPARVAFITCNot specifiedHuman
CSB-PA868328LD01HUPARVABiotinELISAHuman

When selecting antibodies, researchers should consider validation status, application compatibility, and cross-reactivity with other species if comparative studies are planned. Verification through multiple antibodies is recommended for confirming specificity of signals.

What expression systems are available for producing recombinant PARVA protein for structural and functional studies?

Researchers have multiple options for recombinant PARVA protein production:

Expression SystemProduct CodeAdvantagesTypical Applications
YeastCSB-YP868328HUEukaryotic processing, High yieldStructural studies, Antibody production
E. coliCSB-EP868328HUCost-effective, ScalableBinding assays, Biochemical characterization
BaculovirusCSB-BP868328HUPost-translational modificationsFunctional assays, Enzymatic studies
Mammalian cellCSB-MP868328HUNative folding, Human modificationsInteraction studies, Cell-based assays
Biotinylated E. coliCSB-EP868328HU-BOriented immobilizationSPR, Pull-down assays

Selection should be guided by the intended experimental application, with consideration for required protein folding, post-translational modifications, and yield requirements.

What are optimal cell models for investigating PARVA function in vascular contexts?

When studying PARVA in vascular biology, researchers should consider these cell models:

  • Human umbilical vein endothelial cells (HUVECs): Well-characterized primary cells for angiogenesis studies

  • Human aortic smooth muscle cells (HASMCs): Appropriate for studying PARVA in vascular contractility

  • Immortalized endothelial cell lines (e.g., EA.hy926): Useful for genetic manipulation studies

  • Co-culture systems combining endothelial and smooth muscle cells: Essential for studying PARVA's role in cell-cell adhesion between these vascular components

  • 3D organotypic cultures: Provide physiologically relevant architecture for studying PARVA in vessel formation

These models can be complemented with appropriate extracellular matrix components to recapitulate specific vascular environments.

How can researchers effectively visualize PARVA localization and dynamics in living cells?

Visualizing PARVA in living systems requires specific methodological approaches:

  • Fluorescent protein fusions (GFP, mCherry) with careful validation of functionality

  • SNAP or Halo tag systems for flexible labeling options

  • Fluorescent antibody fragments for endogenous protein tracking

  • Correlative light-electron microscopy for ultrastructural localization

  • FRAP (Fluorescence Recovery After Photobleaching) for dynamic mobility assessment

  • TIRF microscopy for focal adhesion-specific visualization

When designing visualization experiments, researchers should control for expression level artifacts and validate that tagged versions retain native functionality through rescue experiments in PARVA-depleted cells.

What quantitative assays best measure PARVA's functional impact on cell migration and adhesion?

Multiple quantitative approaches can assess PARVA's functions:

  • Wound healing assays with automated area measurement

  • Single-cell tracking for migration speed and directionality

  • Microfluidic gradient chambers for chemotactic responses

  • Traction force microscopy to measure cellular force generation

  • Atomic force microscopy for cell-substrate adhesion strength

  • FRET-based tension sensors for molecular force transmission

  • Cell spreading kinetics on various extracellular matrix proteins

Ideally, researchers should combine multiple assays to comprehensively characterize PARVA's role in both migration and adhesion processes, as these cellular functions are mechanistically linked but can be differentially affected.

How should researchers design knockdown versus knockout approaches for studying PARVA?

When manipulating PARVA expression, researchers must consider several methodological factors:

  • siRNA/shRNA approaches: Provide acute, partial reduction suitable for studying dose-dependent effects and avoiding developmental compensation

  • CRISPR/Cas9 knockout: Enables complete elimination for studying absolute requirement but may trigger compensatory mechanisms

  • Inducible systems: Allow temporal control to distinguish developmental versus acute functional requirements

  • Domain-specific approaches: Can target specific functions while preserving others through truncation or point mutations

  • Rescue experiments: Essential controls to confirm specificity of observed phenotypes

Careful experimental design should include appropriate controls and validation of knockdown/knockout efficiency at both RNA and protein levels.

What considerations are important when selecting species-specific reagents for comparative PARVA studies?

Cross-species research on PARVA requires careful reagent selection:

SpeciesAvailable ReagentsCross-Reactivity Considerations
HumanComprehensive antibody panel, Multiple recombinant protein optionsSome antibodies cross-react with rodent PARVA
MouseRecombinant proteins from multiple expression systemsKey model for developmental studies
RatRecombinant proteins from multiple expression systemsUseful for cardiovascular physiology studies

When designing comparative studies, researchers should:

  • Validate antibody cross-reactivity empirically rather than relying solely on manufacturer claims

  • Consider sequence homology when interpreting functional conservation

  • Account for species-specific differences in expression patterns and binding partners

How can researchers effectively isolate and study PARVA-containing protein complexes?

To study PARVA in its native protein complexes:

  • Optimize cell lysis conditions to preserve interactions (detergent type and concentration)

  • Consider crosslinking approaches for transient interactions

  • Implement tandem affinity purification for high-purity complex isolation

  • Use proximity-dependent biotinylation (BioID, TurboID) to identify interaction neighborhoods

  • Combine with mass spectrometry for unbiased partner identification

  • Validate key interactions through reciprocal immunoprecipitation

These approaches should be tailored to the specific cellular context under investigation, as PARVA complexes may vary across cell types and conditions.

What statistical approaches are recommended for analyzing quantitative data on PARVA localization patterns?

Quantitative analysis of PARVA localization requires robust statistical methods:

  • Pearson's or Mander's correlation coefficients for colocalization analysis

  • Density-based clustering algorithms for focal adhesion pattern analysis

  • Bootstrapping approaches for confidence interval estimation in small sample sizes

  • Mixed-effects models for experiments with multiple cells from multiple experiments

  • Multivariate analysis for correlating localization with functional outcomes

  • Machine learning approaches for pattern recognition in complex localization phenotypes

Researchers should clearly report not only statistical significance but also effect sizes to enable proper interpretation of biological relevance.

How should researchers approach conflicting data on PARVA function across different cell types?

When facing contradictory findings about PARVA function:

  • Systematically document cell type-specific differences in PARVA expression level and isoform distribution

  • Characterize differences in key binding partners across cell types

  • Consider the influence of extracellular matrix composition and stiffness

  • Evaluate activation states of upstream signaling pathways

  • Develop unified models that incorporate cell type as a variable

  • Implement mathematical modeling to identify parameters that could explain divergent behaviors

This systematic approach can transform apparent contradictions into insights about context-dependent regulation of PARVA function.

Product Science Overview

Structure and Function

Parvin Alpha contains two calponin-homology (CH) domains, which are crucial for its function. These domains allow Parvin Alpha to bind to actin filaments, a key component of the cell’s cytoskeleton . The protein also interacts with integrin-linked protein kinase (ILK) and paxillin, which are involved in cell signaling and adhesion .

The N-terminus of Parvin Alpha has two nuclear localization signals and three potential SH3-binding sites, which are important for its localization and function within the cell . The protein’s structure allows it to play a significant role in the regulation of cell adhesion and cytoskeleton organization .

Gene and Expression

The PARVA gene is located on chromosome 11p15.3 and contains 13 exons . The gene produces multiple transcripts through the use of different polyadenylation signals. These transcripts encode a protein with a molecular mass of approximately 42.3 kDa .

Parvin Alpha is expressed in most tissues, with the highest expression levels observed in the kidney and heart . It is also expressed throughout mouse embryonic development, indicating its importance in early development .

Recombinant Production

Recombinant human Parvin Alpha is produced using various expression systems, including E. coli . The recombinant protein is often tagged with GST (Glutathione S-transferase) or His (Histidine) tags to facilitate purification and detection . The recombinant protein is typically lyophilized and can be stored at -20°C to -80°C for long-term stability .

Applications

Recombinant Parvin Alpha is used in various research applications, including studies on cell adhesion, cytoskeleton organization, and signal transduction. Its ability to bind actin and interact with other proteins makes it a valuable tool for understanding the molecular mechanisms underlying these processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.